Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant Safety in Renal Transplant Recipients
NCT00525681Phase 4Completed
- Sponsor
- University of Oslo School of Pharmacy
- Start
- Sep 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rimonabant in obesity, sponsored by University of Oslo School of Pharmacy. Started Sep 2007; status: completed.
02
Drugs
rimonabant
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00525681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525681.